After being delayed three times in the past five years, ICD-10 is finally upon us. The industry is no longer fixated on the ICD-10 deadline but instead is shifting its focus to the impact the transition will have on healthcare in the U.S. Many, particularly physicians practices and small hospitals, are bracing for the worst. The biggest fear is that an avalanche of claims denials in the wake of ICD-10 will cause substantial disruptions in cash flow and revenue for these providers.
Telemedicine finally seems to be gaining traction in healthcare. In early August, Mordor Intelligence released a research report titled Global Telemedicine Market — Growth, Trends & Forecasts (2015-2020) that predicts the global market for telemedicine will be worth more than $34 billion by the end of the decade. North America is recognized as the largest contributor to this growth, accounting for more than 40 percent of the global market size.
When attestations for Stage 1 of the EHR Meaningful Use (MU) program began in 2011, it seemed like the healthcare industry was on the right path to ushering in a fruitful digital era that would benefit clinicians and patients alike.
Many industry leaders championed a free market approach to healthcare during the 12th Annual World Health Care Congress last week. Here are a few key reasons why I don’t think this model is “the fix” our industry so desperately needs.
The ONC must ensure the MU criteria related to interoperability isn’t too vague or broad.
Why 2015 may be the year telehealth finally goes mainstream and what providers can expect once it does
According to a recent Medscape survey, 46% of physicians say they are burned out. How much is the drive towards health IT adoption contributing to this epidemic?
Just when the Meaningful Use program was on life support, the ONC makes two key announcements that seem to have healthcare leaders rallying around the program (and the organization) once again.
A new Harris Poll suggests cost fears keep many people from visiting the doctor even if they are insured. This telling data is yet another illustration of the need for price transparency in healthcare.
